CROMA Ophthalmic Solution

Sodium cromoglycate, Tetrahydrozoline HCl
4% + 0.05%
A.H.ROBINS
Pack size 1 Dropper Container (10 ml)
Dispensing mode
Source
Agent
Retail Price 31.65 AED

Indications

CROMA Ophthalmic Solution is used for: CROMOGLICIC ACID
For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis
TETRYZOLINE
For temporary relief of discomfort and redness of the eye due to minor eye irritations

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Sodium cromoglycate, Tetrahydrozoline HCl :

Mechanism of Action

CROMOGLICIC ACID
Cromoglicate inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (srs-a), mediators of type i allergic reactions. Cromoglicate also may reduce the release of inflammatory leukotrienes. Cromoglicate may act by inhibiting calcium influx
TETRYZOLINE
Tetryzoline is an alpha-adrenergic agonist. Its primary action is the constriction of conjunctival blood vessels, which serves to decrease eye redness caused by minor ocular irritants

Note

CROMA 4% + 0.05% Ophthalmic Solution manufactured by A.H.ROBINS. Its generic name is Sodium cromoglycate, Tetrahydrozoline HCl. CROMA is availble in Saudi Arabia. Farmaco SA drug index information on CROMA Ophthalmic Solution is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Sodium cromoglycate, Tetrahydrozoline HCl :